03/21/2016

Development of novel Fluorescence-activated cell sorting (FACS) and Immunoprecipitation (IP)/Western-Blot assays to characterize antibody therapies

Dr Ralf Geiben Lynn, Senior Research Scientist at Cambridge Biomedical has authored our latest white paper.

Development of novel Fluorescence-activated cell sorting (FACS) and Immunoprecipitation (IP)/Western-Blot assays to characterize antibody therapies


Click on the above title to access the paper

  
Latest News   

 Subscribe to our blog

Events

APA

Providence RI 17-20th September

PBSS

Cambridge, MA 29 September

For existing clients & test results please contact 
Customer Service:617.456.0800
All rights reserved. Cambridge Biomedical, the Cambridge Biomedical logo, Science and Service, and Custom
Solutions for Life Sciences Companies are registered or unregistered trademarks of Cambridge Biomedical Inc.
|     Privacy Statement     | Terms of Use